Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
British Journal of Cancer
|
October 19, 2006
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
A Scardocci, F Guidi, F D'Alo', et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2009
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas
S Hohaus, M Giachelia, G Massini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 15, 2007
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma
S Hohaus, M Giachelia, A Di Febo, et al.
British Journal of Cancer
|
April 3, 1999
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
S Hohaus, L Funk, S Martin, et al.
Neurology
|
February 25, 2011
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes
S K Hasan, F Buttari, T Ottone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 1, 1996
Localization of aspergillosis to the central nervous system among patients with acute leukemia: report of 14 cases. Gruppo Italiano Malattie Ematologiche dell'Adulto Infection Program
L Pagano, P Ricci, M Montillo, et al.
Frontiers in Oncology
|
March 4, 2026
Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
S Pelliccia, A Di Rocco, G Palumbo, et al.
Frontiers in Oncology
|
March 27, 2026
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
S Pelliccia, A Di Rocco, G Palumbo, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
British Journal of Cancer
|
October 19, 2006
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
A Scardocci, F Guidi, F D'Alo', et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2009
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas
S Hohaus, M Giachelia, G Massini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 15, 2007
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma
S Hohaus, M Giachelia, A Di Febo, et al.
British Journal of Cancer
|
April 3, 1999
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
S Hohaus, L Funk, S Martin, et al.
Neurology
|
February 25, 2011
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes
S K Hasan, F Buttari, T Ottone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 1, 1996
Localization of aspergillosis to the central nervous system among patients with acute leukemia: report of 14 cases. Gruppo Italiano Malattie Ematologiche dell'Adulto Infection Program
L Pagano, P Ricci, M Montillo, et al.
Frontiers in Oncology
|
March 4, 2026
Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
S Pelliccia, A Di Rocco, G Palumbo, et al.
Frontiers in Oncology
|
March 27, 2026
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
S Pelliccia, A Di Rocco, G Palumbo, et al.
Page
of 5